Teva Pharmaceuticals
Macquarie Park, Australia tevapharm.com From their website, Nov 2026
Work here? Claim this listing
About
Teva Pharmaceuticals is a global pharmaceutical company that develops, manufactures, and commercializes medicines for patients in 57 markets. Its work spans generic medicines, biosimilars, innovative medicines, and research programs focused on neuroscience, immunology, respiratory conditions, central nervous system disorders, and oncology.
Services
Generic medicines development
Develops generic medicines designed to match branded drugs in active ingredients, strength, dosage form, safety, quality, efficacy, and clinical effect.
Generic medicines regulation
Supports the regulatory approval process for generic medicines across different regions and countries.
Generic medicines out-licensing
Out-licenses a portfolio of generic pharmaceuticals and provides registration dossiers and launch support through Medis.
Biosimilar medicines development and manufacturing
Develops and manufactures biosimilars and supports their global delivery and commercialization.
Collaborative research and investigator-sponsored studies
Accepts investigator study requests through a submission management system and reviews submissions for completion, clarity, and compliance.
Clinical development
Supports the stages of clinical development, including discovery, optimization, in vivo testing, toxicology, and clinical trials.
Product quality complaint handling
Provides a form for reporting product quality concerns for selected products.
Research and development
Advances drug discovery and development using scientific expertise and emerging technologies.
8 more services
- Innovative medicines development
- Generic medicines
- Biologics development
- Biologics manufacturing
- Antibody discovery
- Bioanalysis
- Clinical biomarkers
- Drug product tech transfer
- Turnaround
- Registration should take about 10 minutes to complete.
- 4 minutes
- 6 Minutes
- 8 Minutes
- 5 Minutes
Capabilities
- Assays and studies
- Bioanalysis
- Antibodies
- Chemical and in vitro biological systems
- Toxicology studies
- Drug metabolism studies
- Bioequivalence studies
4 more
- Interventional clinical trials
- Observational studies
- Expanded access studies
- Clinical biomarkers
- Scale and capacity
- Approximately 37,000 employees
- 57 markets
- More than 30 biosimilar products approved or in development
- 7 biosimilars launched since 2020
- 15 biosimilars in market
- 16 biosimilar products in the pipeline
3 more
- 185+ pharmaceutical products
- 140+ countries
- More than 1,160 generic products in its development pipeline
- Therapeutic areas
- Neuroscience
- Immunology
- Respiratory conditions
- Central nervous system
- Oncology
- Schizophrenia
6 more
- Bipolar disorder
- Tourette syndrome
- ADHD
- Huntington's disease
- Common diseases
- Rare diseases
Modalities and species
- Modalities
- Antibody
- Biosimilar
- Species and models
- In vivo animal disease models
- Healthy participants
Industries served
- Pharmaceuticals
- Biopharmaceuticals
- Healthcare
Company
- Type
- Manufacturer
- Founded
- 1901
- Size
- 5001+ employees
- Quality
- Rigorous regulatory evaluation (biosimilars) · same quality standards (generic drugs) · bioequivalent (generic drugs)
Locations
- Based in
- Macquarie Park, Australia
- Sites
- Netanya, Israel
- Ulm, Germany
- Philadelphia, USA
- Serves
- Worldwide, Europe, North America, International markets, 57 markets worldwide